Verrica Pharmaceuticals

VRCA · NASDAQ

$3.47+$0.03 (+0.87%)TodayMarket closed ·
Prev close $3.44

Who owns VRCA

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 69.8% of VRCA’s shares.

  • Manning (Paul B.)26.5%
  • BKB Growth Investments LLC19.5%
  • Caligan Partners, LP5.4%
  • Cannell Capital, LLC4.6%
  • Next 6 largest institutions13.8%
  • All other shareholders30.2%
Top institutional holders of VRCA
HolderShares% of shares
Manning (Paul B.)4.56M26.53%
BKB Growth Investments LLC3.35M19.49%
Caligan Partners, LP923.91K5.38%
Cannell Capital, LLC783.92K4.56%
Affinity Asset Advisors LLC707.34K4.12%
Velan Capital Investment Management LP471.56K2.74%
Armistice Capital LLC426.30K2.48%
Boothbay Fund Management, LLC280.73K1.63%
Vanguard Capital Management, LLC279.31K1.63%
Rieger (Jayson)208.29K1.21%

Largest mutual fund holders

Top mutual fund holders of VRCA
HolderShares% of shares
Vanguard Total Stock Market Index Fund216.44K1.26%
Vanguard Extended Market Index Fund135.47K0.79%
Fidelity Extended Market Index Fund60.99K0.35%
iShares Micro-Cap ETF36.72K0.21%
Fidelity Total Market Index Fund20.50K0.12%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $210.89K (6 trades) of VRCA on the open market, with no sales.

Latest VRCA insider transactions
InsiderTypeSharesValue
Rosenberg Noah L.Buy2.03K$9.99K
Kirby John J.Buy5.00K$24.65K
Zawitz DavidBuy6.00K$29.88K
Rieger JaysonBuy5.00K$24.55K
Rosenberg Noah L.Buy4.20K$20.62K
Rieger JaysonBuy20.00K$101.20K
Zawitz DavidAward171.34K—
Rieger JaysonAward512.27K—
Eichenfield LawrenceAward16.00K—
Nguyen DiemAward16.00K—

Short interest

Settled Sep 30, 2026

Shares short
196.22K
Days to cover
4.06
% of shares outstanding
1.14%
Average daily volume
48.28K
Change since last report
−3.2%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.